SynthesisEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Endoscopic dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction: A systematic review and pooled analysis of powered vs. non-powered technique.
Synthesis in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeEndoscopic dacryocystorhinostomy (eDCR) has become the standard surgical treatment for primary acquired nasolacrimal duct obstruction (PANDO), demonstrating safety and success rates comparable to external DCR. However, surgical failure remains a concern, often related to aberrant mucosal healing, synechiae formation, and ostium restenosis. The optimal surgical approach, particularly regarding powered versus non-powered techniques and the role of adjunctive treatments such as silicone stents and mucosal flaps, remains debated.
methodsA systematic review and pooled analysis were conducted in accordance with PRISMA guidelines. The protocol was registered on PROSPERO (CRD420251014988). PubMed, Scopus, and Web of Science were searched through March 2025. Eligible studies included adults with PANDO undergoing primary eDCR, with detailed reporting of technique, outcomes, and at least 50 cases. Data were extracted and stratified by surgical approach (powered vs. non-powered) and adjunctive treatments (stenting, mucosal flaps).
resultsA total of 107 studies comprising 17,415 DCRs were included. Overall surgical success was 87.5%, with no significant difference between powered (87.7%) and non-powered (87.6%) approaches (OR 0.95, 95% CI 0.87-1.05, p = 0.316). Laser-assisted DCR was associated with significantly lower success (OR 0.80, p = 0.001). Mucosal flap preservation improved outcomes, while silicone stenting showed no consistent benefit. Non-powered techniques were associated with shorter operative times.
conclusionsPowered and non-powered eDCR techniques demonstrate comparable efficacy in managing PANDO. Non-powered approaches, particularly with mucosal flap preservation, may offer practical advantages, reduced morbidity, and shorter operative times, supporting their role as a valuable alternative in clinical practice.
Indexed as
Identifiers
41786947What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.